Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Vilon

KE, L-Lys-L-Glu, lysylglutamic acid

Quick Stats
Studies 40
Trials 100
Unknown NA INTERVENTIONAL NCT04168489

Evaluation of the Effect of TMS on Primary Dysmenorrhea

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Based on the pain threshold and visual simulation score, primary dysmenorrhea patients will be divided into treatment effective group or non-effective group.According to the functional magnetic resonance imaging, the investigators investigate whether there is characteristic or secondary brain features before and after rTMS intervention.

Detailed Description

Long term primary dysmenorrhea may induce a series of disorders involving psychology, lower quality of life, or even developing chronic organic lesion or chronic pain. Effective symptom improvement is urgently needed. During the Non-pharmaceutical interventions, repetitive transcranial magnetic stimulation (rTMS) is received preliminary approval because of its noninvasive and safe analgesic effect. In this randomized single blind longitudinal study, the investigators investigate the analgesic effect of rTMS in long term moderate-to-severe primary dysmenorrhea women. Based on the pain threshold and visual simulation score, primary dysmenorrhea patients will be divided into treatment effective group or non-effective group. According to the functional magnetic resonance imaging, the investigators investigate whether there is characteristic or secondary brain features before and after rTMS intervention. By combining pre and post performances of the degree of dysmenorrhea, behavioral data and sensitive hematological indicators, the investigators intend to build an association model between brain and pain development curve. Using correlation and multiple regression analysis method, the investigators intend to find sensitive neuroimaging biomarkers in predicting the analgesic effect of rTMS. The current study is not only contributing to improve the central nervous systematic mechanism of rTMS in chronic pelvic pain, but also significant for clinical effective treatment based on neuroimaging predictive markers.

Interventions

Name: active rTMS
Type: DEVICE
Description: (rTMS) is received preliminary approval because of its noninvasive and safe analgesic effect.
Name: sham rTMS
Type: DEVICE
Description: The sham rTMS is inactive and similar to placebo effect.

Primary Outcomes

Measure: Evaluation of effect of rTMS for primary dysmenorrhea
TimeFrame: From 1 month before treatment to 3 months after treatment for each volunteers(through study completion, an average of 2 years)
Description: Assessments using Visual Analog Score for pain(Units on a Scale) in primary dysmenorrhea during menstrual phase to evaluate the effect of rTMS

Trial Information

NCT ID

NCT04168489

Status

Unknown

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Last Updated

December 15, 2025